Bank of America’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Bank of America’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,452	Closed	-$98K	–	7548
2019 Q3	$98K	Sell	16,452 -16,342	-50%	-$167K	﹤0.01%	6060
2019 Q2	$410K	Buy	32,794 +8,604	+36%	+$115K	﹤0.01%	5198
2019 Q1	$310K	Buy	+24,190	New	+$325K	﹤0.01%	5298

Other funds holding MITO

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's MITO Position: Q4 2019 in Review

Bank of America sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2019, closing a stake of 16,452 shares — an estimated $98K sold.

Bank of America first reported a position in MITO in Q1 2019 and held it in 3 quarters. The position peaked at $410K in Q2 2019. 5 funds tracked by Wall St. Rank hold MITO as of Q4 2019.

Bank of America reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2019 after selling out during the quarter.
Bank of America sold 16,452 Stealth BioTherapeutics Corp. ADS shares in Q4 2019, an estimated $98K.
Bank of America first reported a position in Stealth BioTherapeutics Corp. ADS in Q1 2019 and held it in 3 quarters.
Bank of America's Stealth BioTherapeutics Corp. ADS position peaked at $410K in Q2 2019.
5 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.